Wednesday, April 6, 2011

Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?

Movement Disorders, 26: n/a. doi: 10.1002/mds.23711

García-Giménez, J. L., Sanchis-Gomar, F. and Pallardó, F. V.

CIBERER, Biomedical Network Research Centre on Rare Diseases, Valencia, Spain
Department of Physiology, Faculty of Medicine, University of Valencia, Valencia, Spain
Fundación del Hospital Clínico Universitario de Valencia. FIHCUV-INCLIVA, Valencia, Spain

Keywords: Friedreich's ataxia; rare disease; neurological symptoms; hypertrophic cardiomyopathy; rosiglitazone; pioglitazone; heart failure; peroxisome proliferator-activated receptor-gamma coactivator-1α.

No comments:

Post a Comment